Understanding Quinolone Resistance and Its Implications
Bacterial resistance to quinolones is an important clinical concern. Resistance can develop through mutations in DNA gyrase or topoisomerase IV, reducing drug binding effectiveness. Other mechanisms include decreased drug permeability and active efflux systems.
Inappropriate use accelerates resistance development. Prescribing quinolones for non-bacterial infections or failing to complete treatment courses undermines their long-term effectiveness.
Quinolones are often considered in the treatment of complicated urinary tract infections, intra-abdominal infections, and certain respiratory infections encountered in hospitalized patients. Their ability to achieve therapeutic concentrations in deep tissues makes them useful when infections extend beyond superficial sites. In addition, quinolones penetrate biofilms more effectively than some other antibiotics, which can be beneficial in device-associated infections.
Hospital use of quinolones is guided by diagnostic testing and infection severity. Microbiological culture and sensitivity testing help determine whether a quinolone is appropriate for a specific pathogen. This targeted approach reduces unnecessary exposure and supports antimicrobial stewardship principles.
Antibiotic stewardship programs emphasize responsible quinolone use to preserve their clinical value. Awareness and education play a key role in resistance prevention.